SEC Company Response from China Medical Technologies, Inc. (CIK 0001326059) — Jul 15, 2005
China Medical Technologies, Inc. (CIK 0001326059)
Date: July 15, 2005 · CIK: 0001326059 · Accession: 0001193125-05-143274
AI Filing Summary & Sentiment
Letter
Via Edgar Division of Corporation Finance Securities and Exchange Commission Re: China Medical Technologies, Inc. Registration Statement on Form F-1 Publicly Filed on July 15,
Dear Messrs. Mancuso and Hunt:
On behalf of our client, China Medical Technologies, Inc., a company organized under the laws of the Cayman Islands (the “Company”), we are filing herewith the Company’s Registration Statement on Form F-1 (the “Registration Statement”).
If you have any questions, please do not hesitate to contact me at (+852) 2912-2503.
Best regards,
/s/ David T. Zhang
Show Raw Text
CORRESP 2 filename2.htm SEC letter for public filing July 15, 2005 Via Edgar Mr. Russell Mancuso, Branch Chief Mr. Donald C. Hunt, Attorney-Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Medical Technologies, Inc. Registration Statement on Form F-1 Publicly Filed on July 15, 2005 Dear Messrs. Mancuso and Hunt: On behalf of our client, China Medical Technologies, Inc., a company organized under the laws of the Cayman Islands (the “Company”), we are filing herewith the Company’s Registration Statement on Form F-1 (the “Registration Statement”). If you have any questions, please do not hesitate to contact me at (+852) 2912-2503. Best regards, /s/ David T. Zhang David T. Zhang of LATHAM & WATKINS LLP cc: Xiaodong Wu, Chairman and Chief Executive Officer, China Medical Technologies, Inc. Sam Tsang, Chief Financial Officer, China Medical Technologies, Inc. Shuang Zhao, Latham & Watkins LLP, Hong Kong Leiming Chen, Shearman & Sterling LLP, Hong Kong Jack Chow, KPMG, Hong Kong Kenneth Bunce, KPMG-US Capital Markets Group, Hong Kong